Search

everythinglearnresearchcommunity

for

Search:↓

Postmenopausal women with hyperandrogenism didn't have better metabolic health even after their testosterone levels became normal.

The Alopecia Areata Assessment Tool (ALTO) effectively identifies alopecia areata from other hair loss types but needs more validation.

Combining platelet-rich plasma therapy with low dose oral minoxidil improved hair growth in men with hair loss, with slightly higher satisfaction at the higher minoxidil dose.

Women also use 5α-reductase inhibitors, and their effects differ from men.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

Women with mild acne are more likely to have polycystic ovary syndrome (PCOS) than those without acne.

Younger transgender women have surgery earlier, are mostly attracted to men, and show more preoperative depression that improves after surgery compared to older transgender women.

A new botanical treatment improved hair growth and symptoms in lichen planopilaris patients.

Hormonal changes and psychological issues can cause sexual dysfunction in postmenopausal women. Behavioral therapy is recommended first, with hormone replacement helping some symptoms but not libido. Testosterone can improve libido, but its effects on overall sexual function are unclear. Emotional and relationship issues should be addressed before using medication, and the benefits and risks of testosterone supplementation should be considered.

Nonobese, normotensive Indian women with PCOS may have a higher risk of heart problems linked to inflammation and insulin resistance.

The summit aimed to speed up finding treatments for alopecia areata.

The session covered updates on skin treatments, including radiotherapy, imiquimod, acitretin, JAK inhibitors, and strategies for managing rosacea and preventing surgical infections.

Finasteride may help postmenopausal women with hair loss but is not effective for all and should be used cautiously in premenopausal women.

Gene therapy with the Math1 gene helped regenerate balance-related cells and improve balance in mice.

Liraglutide caused significant weight loss in some obese women with PCOS, especially those with severe obesity and insulin resistance.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

Scalp cooling significantly reduces hair loss in chemotherapy patients.

Juvéderm fillers effectively reduce wrinkles for up to 21 months with less filler needed for repeat treatments.

The testosterone patch and gel are both effective, but they have different absorption patterns and effects on hormone levels.

Personality traits and anxiety affect hair loss patients' quality of life.

Vegetarian Indian women with PCOS have higher inflammation levels than non-vegetarians.

Different types of dog hair loss are linked to problems starting the hair growth phase and early hair cycle ending.

Low-level light therapy may help hair regrowth, but more research is needed.

Platelet-Rich Plasma (PRP) treatment can potentially increase hair density and quality in people with hair loss, but more research is needed to confirm its effectiveness.

Sodium selenate was found to be safe and possibly slows Alzheimer's progression, but more research is needed.

PRGF treatment safely and effectively helps hair loss.

Herbal formula shows promise for hair loss treatment.

Both treatments for alopecia areata showed similar modest effectiveness.